Helaina on track to deliver breast milk-equivalent baby formula

Helaina, the creators behind advanced infant formula with proteins identical to those found in breast milk, recently announced the expansion of its leadership team on the heels of a $20 million Series A fundraise. Three new hires, Anthony Clark, Chief Technology Officer; Marie-Claude Tremblay, Head of Infant Formula; and Ashley Larkin, Head of Talent, mark a milestone in the company’s growth.

“This group of all-star leaders bring industry expertise to Helaina as we accelerate our growth and work toward bringing our advanced infant formula to market, which will provide infants with crucial bioactive properties that traditional formula lacks. In the middle of a national infant formula shortage, it’s now more important than ever to deliver more options for parents to feed their babies, and I’m confident this team will make that a reality,”said Laura Katz, Founder and CEO of Helaina.

Navigating regulatory hurdles

Helaina utilizes precision fermentation to recreate immune-equivalent proteins previously only available in breast milk, bridging the gap between traditional formula and breastfeeding.

“I understand the regulatory challenges Helaina will face,” Said Anthony Clark, Chief Technology Officer at Helaina. “And, I’m excited to help guide the team to more effectively and more nimbly negotiate those challenges, ultimately bringing Helaina’s enhanced infant formula to market quicker.”

“When innovating for infant nutrition, there is a higher bar for safety at every stage of development and manufacturing,” explained Katz, a food scientist. “We welcome this high bar, and believe that it is a gateway for the future of nutrition. Making nutritional ingredients like bioactive proteins and lipids through fermentation for the purpose of innovating infant nutrition has the potential to unlock key components for the future of nutrition for all populations.”


Leave a Comment